DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cymserine
Cymserine
(12) Patent Application Publication (10) Pub. No.: US 2014/0371260 A1 Moebius (43) Pub
Global Current Trends in Drug Designing for Management of Type-2 Diabetes and Neurodegenerative Disorders
Methods and Combination Therapies for Treating Alzheimer's Disease
Screening for Cholinesterase Inhibitors in Selected Fruits and Vegetables, Ejpau, 15(2), #06
(12) Patent Application Publication (10) Pub. No.: US 2012/0157420 A1 Schneider (43) Pub
Acetylcholinesterase Inhibitors of Natural Origin
Biomolecular Screening for Inhibitors of Butyrylcholinesterase
(12) Patent Application Publication (10) Pub. No.: US 2010/0152.108A1 Hung Et Al
Neuroprotective Natural Products Neuroprotective Natural Products
Selective Butyrylcholinesterase Inhibition Elevates Brain Acetylcholine, Augments Learning and Lowers Alzheimer Я-Amyloid Pepti
Fig. 2 ACADIA
Botulinum Toxin
(12) Patent Application Publication (10) Pub. No.: US 2011/0201597 A1 CHASE Et Al
CHAPTER 6 Specific Cholinesterase Inhibitors: a Potential Tool to Assist in Management of Alzheimer Disease Nigel H
(12) Patent Application Publication (10) Pub. No.: US 2005/0182044 A1 Bruinsma (43) Pub
Butyrylcholinesterase and the Cholinergic System
(12) Patent Application Publication (10) Pub. No.: US 2006/0018839 A1 Leni Et Al
MUSHTAQAHMED.Pdf
Top View
(12) Patent Application Publication (10) Pub. No.: US 2002/0094999 A1 Greig Et Al
And Butyrylcholinesterase Inhibitors Reduce Amyloid-Β Ex Vivo
Selective Butyrylcholinesterase Inhibition Elevates Brain Acetylcholine, Augments Learning and Lowers Alzheimer Я-Amyloid Pepti
Dissociation Between the Potent B-Amyloid Protein Pathway Inhibition and Cholinergic Actions of the Alzheimer Drug Candidates Phenserine and Cymserine
Contemporary Medicinal-Chemistry Strategies for the Discovery of Selective Butyrylcholinesterase Inhibitors
(12) Patent Application Publication (10) Pub. No.: US 2014/0349976 A1 HACKSELL Et Al
Mohd. Haris Siddiqui-CNS&ND-MS
Global Current Trends in Drug Designing for Management of Type-2 Diabetes and Neurodegenerative Disorders
Chiral Separation, X-Ray Structure, and Biological Evaluation of a Potent and Reversible Dual Binding Site Ache Inhibitor
(12) Patent Application Publication (10) Pub. No.: US 2010/0130537 A1 Mivagawa (43) Pub
1 Akademie Věd České Republiky Teze Disertace K Získání Vědeckého Titulu "Doktor Věd" Ve Skupině: Chemick
Biological Assessment of Novel Series of Multitarget-Directed Ligands Based on Donepezil to Be Used In
Director's Report - September 2005
AD Causes Queries Appendix 9A-1
Molecular Interaction Study of N -P
Molecular Interaction Study of N -P-Fluorobenzyl-Cymserine with TNF
Lamiaceae Family Plants As a Potential Anticholinesterase Source in the Treatment of Alzheimer's Disease
WO 2010/098487 Al
Cholinesterases, a Target of Pharmacology and Toxicology
Amaryllidaceae Alkaloids of Norbelladine-Type As Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitor
Conjugates of Methylene Blue with Γ-Carboline Derivatives As New Multifunctional Agents for the Treatment of Neurodegenerative
(12) Patent Application Publication (10) Pub. No.: US 2009/0042939 A1 Ieni Et Al
Inhibition of Acetylcholinesterase by Extracts and Constituents from Angelica Archangelica and Geranium Sylvaticum Steinthor Sigurdsson* and Sigmundur Gudbjarnason